Chiara Corradi Selected Research

Interferon-alpha2b

1/2008

Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Corradi Research Topics

Disease

2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2021
1	Neoplasms (Cancer) 01/2022
1	Ascites 12/2020
1	Hemorrhage 11/2020
1	Hepatitis C 11/2020
1	Fibrosis (Cirrhosis) 01/2008
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2008
1	Infections 01/2008

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Long Noncoding RNAIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 12/2020
1	DiureticsIBA 12/2020
1	SaltsIBA 12/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	Cytochrome P-450 CYP3AIBA 11/2020
1	AnticoagulantsIBA 11/2020
1	Antiviral Agents (Antivirals)IBA 11/2020
1	InterferonsIBA 01/2008
1	Interferon-alpha2bIBA 01/2008
1	Ribavirin (Virazole)FDA LinkGeneric 01/2008

Therapy/Procedure

1	Liver Transplantation 12/2020
1	Transjugular Intrahepatic Portasystemic Shunt 12/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2020